Suchergebnisse - "Glioma"

PubPharm (917)

101

Targeting IDH-Mutant Glioma

enthalten in: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics | 2022

von Miller, J.

102

Major Features of the 2021 WHO Classification of CNS Tumors

enthalten in: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics | 2022

von Smith, H. | Wadhwani, N. | Horbinski, C.

103

H3K27me3 in Diffuse Midline Glioma and Epithelial Ovarian Cancer : Opposing Epigenetic Changes Leading to the Same Poor Outcomes

enthalten in: Cells | 2022

von Day, C. | Hinchcliffe, E. | Robinson, J.

104

Reversal of cancer gene expression identifies repurposed drugs for diffuse intrinsic pontine glioma

enthalten in: Acta neuropathologica communications | 2022

von Zhao, G. | Newbury, P. | Ishi, Y. | +13

105

Single unit analysis and wide-field imaging reveal alterations in excitatory and inhibitory neurons in glioma

enthalten in: Brain : a journal of neurology | 2022

von Gill, B. | Khan, F. | Goldberg, A. | +13

CommentIn: Brain. 2022 Sep 23;:. - PMID 36148603

106

A molecular interactome of the glioblastoma perivascular niche reveals integrin binding sialoprotein as a mediator of tumor cell migration

enthalten in: Cell reports | 2022

von Ghochani, Y. | Muthukrishnan, S. | Sohrabi, A. | +17

107

Development and validation of a prognostic gene expression signature for lower-grade glioma following surgery and adjuvant radiotherapy

enthalten in: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology | 2022

von Qian, D. | Marascio, J. | Tobillo, R. | +8

108

Multiplatform molecular analyses refine classification of gliomas arising in patients with neurofibromatosis type 1

enthalten in: Acta neuropathologica | 2022

von Lucas, C. | Sloan, E. | Gupta, R. | +39

109

T lymphocytes as dynamic regulators of glioma pathobiology

enthalten in: Neuro-oncology | 2022

von Cordell, E. | Alghamri, M. | Castro, M. | +1

CommentIn: Neuro Oncol. 2022 Jun 06;:. - PMID 35660928

110

STAT3 is a biologically relevant therapeutic target in H3K27M-mutant diffuse midline glioma

enthalten in: Neuro-oncology | 2022

von Zhang, L. | Nesvick, C. | Day, C. | +15